Publications Repository

Publications Repository

View item 
  •   Home
  • ICR Divisions
  • Closed Research Teams
  • View item
  • Home
  • ICR Divisions
  • Closed Research Teams
  • View item
JavaScript is disabled for your browser. Some features of this site may not work without it.

PSA levels and cancer detection rate by centre in the European Randomized Study of Screening for Prostate Cancer.

Thumbnail
Date
2010-11
ICR Author
Moss, Susan Mary
Author
Otto, SJ
Moss, SM
Määttänen, L
Roobol, M
Zappa, M
Nelen, V
Kwiatkowski, M
Villers, A
Hugosson, J
Sanchez, AB
de Koning, HJ
Show allShow less
Type
Journal Article
Metadata
Show full item record
Abstract
Background To describe the variation in PSA level by age group and screening round in the ERSPC centres and the variation in cancer detection rates in relation to the underlying prostate cancer incidence.Methods Individual data on men invited for the first and second screening rounds according to protocol (excluding early recalls and interval cancers) were obtained from the central database of the ERSPC (cut-off date 31st December 2006). Data were compared between and within centres for the core age group (55-69 at entry). The cancer detection rate (CDR) was compared with the expected background prostate cancer incidence rate in the absence of screening adjusted for the incidence rate in non-attenders and the control arm (IRS).Results Mean PSA values in the age groups 55-59 years and 65-69 years showed little variation by centre, except for the Dutch centre, where an increase from 1.6 to 1.8 ng/ml and a decline from 2.9 to 2.5ng/ml was observed, respectively. Most tumours were detected at the PSA range 4.0-9.9 ng/ml, with a shift to more cancer detection at 3.0-3.9 ng/ml in the second screening round. There was high variability in the CDR between the centres in both the first (16-46 per 1000) and the second screening rounds (14-50 per 1000). Although the ratio CDR/IRS was less variable, it is somewhat lower in Italy and Switzerland (12 and 14,respectively) and higher in the Netherlands (28), than in most other centres and in Belgium the ratio increased markedly, from 20 to 44 between the first and second rounds.Conclusion There was no clear evidence of a relationship between the underlying incidence and mean PSA levels at screening or the cancer detection rate.
URI
https://repository.icr.ac.uk/handle/internal/2352
DOI
https://doi.org/10.1016/j.ejca.2010.09.012
Collections
  • Closed Research Teams
Subject
Humans
Prostatic Neoplasms
Prostate-Specific Antigen
Biopsy
Sensitivity and Specificity
Sample Size
Age Factors
Aged
Middle Aged
Referral and Consultation
Europe
Male
Multicenter Studies as Topic
Randomized Controlled Trials as Topic
Early Detection of Cancer
Research team
Cancer Screening Evaluation Unit (DoH)
Language
eng
Date accepted
2010-09-03
License start date
2010-11
Citation
European journal of cancer (Oxford, England : 1990), 2010, 46 (17), pp. 3053 - 3060

Browse

All of ICR repositoryICR DivisionsBy issue dateAuthorsTitlesPublication TypesThis collectionBy issue dateAuthorsTitlesPublication Types
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.